Sivik Global Healthcare LLC Biomarin Pharmaceutical Inc Transaction History

Sivik Global Healthcare LLC

$236 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$83.81 - $99.0 $209,525 - $247,500	2,500 Added 4.55%	57,500 $5.02 Million
Q4 2023 Feb 05, 2024	BUY	$76.22 - $98.51 $381,100 - $492,550	5,000 Added 10.0%	55,000 $5.3 Million
Q1 2023 May 05, 2023	SELL	$87.74 - $117.27 $877,400 - $1.17 Million	-10,000 Reduced 16.67%	50,000 $4.86 Million
Q4 2022 Feb 08, 2023	BUY	$80.93 - $108.63 $404,650 - $543,150	5,000 Added 9.09%	60,000 $6.21 Million
Q3 2022 Nov 04, 2022	BUY	$82.16 - $96.94 $616,200 - $727,050	7,500 Added 15.79%	55,000 $4.66 Million
Q2 2022 Aug 10, 2022	BUY	$71.48 - $86.85 $536,100 - $651,375	7,500 Added 18.75%	47,500 $3.94 Million
Q4 2021 Feb 08, 2022	SELL	$71.72 - $91.47 $1.79 Million - $2.29 Million	-25,000 Reduced 38.46%	40,000 $3.53 Million
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $747,700 - $854,700	10,000 Added 18.18%	65,000 $5.02 Million
Q2 2021 Aug 10, 2021	SELL	$75.51 - $84.79 $377,550 - $423,950	-5,000 Reduced 8.33%	55,000 $4.59 Million
Q1 2021 May 12, 2021	SELL	$74.73 - $90.69 $1.49 Million - $1.81 Million	-20,000 Reduced 25.0%	60,000 $4.53 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $1.09 Million - $1.35 Million	15,000 Added 23.08%	80,000 $7.02 Million
Q3 2020 Nov 13, 2020	SELL	$71.87 - $131.03 $11.1 Million - $20.3 Million	-155,000 Reduced 70.45%	65,000 $4.95 Million
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $1.19 Million - $1.86 Million	-15,000 Reduced 6.38%	220,000 $8.13 Million
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $11.1 Million - $15 Million	155,000 Added 193.75%	235,000 $8.39 Million
Q4 2019 Feb 13, 2020	BUY	$64.27 - $86.37 $2.25 Million - $3.02 Million	35,000 Added 77.78%	80,000 $6.76 Million
Q3 2019 Nov 12, 2019	BUY	$67.4 - $85.11 $674,000 - $851,100	10,000 Added 28.57%	45,000 $3.03 Million
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $803,500 - $939,000	-10,000 Reduced 22.22%	35,000 $3 Million
Q1 2019 May 08, 2019	SELL	$84.2 - $98.62 $842,000 - $986,200	-10,000 Reduced 18.18%	45,000 $4 Million
Q3 2018 Nov 13, 2018	SELL	$93.92 - $105.72 $939,200 - $1.06 Million	-10,000 Reduced 15.38%	55,000 $5.33 Million
Q2 2018 Aug 06, 2018	BUY	$76.01 - $99.03 $3.42 Million - $4.46 Million	45,000 Added 225.0%	65,000 $6.12 Million
Q1 2018 May 08, 2018	SELL	$77.67 - $92.63 $4.27 Million - $5.09 Million	-55,000 Reduced 73.33%	20,000 $1.62 Million
Q3 2017 Nov 08, 2017	BUY	$80.6 - $94.95 $6.05 Million - $7.12 Million	75,000	75,000 $6.98 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivik Global Healthcare LLC with notifications on news.

Account